药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Granisetron
Rivastigmine
Rivastigmine may decrease the neuromuscular blocking activities of Vecuronium.
Granisetron
Physostigmine
Physostigmine may decrease the neuromuscular blocking activities of Vecuronium.
Granisetron
Demecarium
Demecarium may decrease the neuromuscular blocking activities of Vecuronium.
Granisetron
Difluocortolone
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Difluocortolone.
Granisetron
Prednisolone acetate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Prednisolone acetate.
Granisetron
Clobetasol
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Clobetasol.
Granisetron
Fluocortolone
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Fluocortolone.
Granisetron
Hydrocortisone butyrate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone butyrate.
Granisetron
Fluocinonide
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Fluocinonide.
Granisetron
Clobetasol propionate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Clobetasol propionate.
Granisetron
Cortisone
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Cortisone.
Granisetron
Betamethasone phosphate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Betamethasone phosphate.
Granisetron
Melengestrol acetate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Melengestrol acetate.
Granisetron
Clocortolone acetate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Clocortolone acetate.
Granisetron
Prednisone acetate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Prednisone acetate.
Granisetron
Methylprednisolone hemisuccinate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Methylprednisolone hemisuccinate.
Granisetron
Prednisolone hemisuccinate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Prednisolone hemisuccinate.
Granisetron
Prednisolone phosphate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Prednisolone phosphate.
Granisetron
Hydrocortisone succinate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone succinate.
Granisetron
Hydrocortisone cypionate
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Hydrocortisone cypionate.